Table 2 Methods comparison based on area under the receiver curve (AUROC) of three drugs in the PDX-D dataset. The best performance is in bold.

From: Molecular pathways enhance drug response prediction using transfer learning from cell lines to tumors and patient-derived xenografts

Drug

Our model

Geeleher et al., Expression

MOLI complete, Expressiona

Paclitaxel

0.80 ± 0.1

0.52

0.69

Gemcitabine

0.53 ± 0.09

0.59

0.52

Erlotinib

0.67 ± 0.16

0.67

0.39

  1. aThe performance scores were adopted from Sharifi-Noghabi (2015)’s paper.
Back to article page